NAVB

Navidea Biopharmaceuticals Inc.
NAVB

Overview Fund Activity
Delisted

NAVB was delisted on the 5th of October, 2023.

Back to rankings

56 hedge funds and large institutions have $5.76M invested in Navidea Biopharmaceuticals Inc. in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 0 closing their positions.

Holders
56
Holders Change
+4
Holders Change %
+7.69%
% of All Funds
1.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
13
Reduced
13
Closed
–
Calls
$24K
Puts
$19K
Net Calls
+$5K
Net Calls Change
+$18K

Top Buyers

1
UBS Group
1
UBS Group
Switzerland
$102K
2
Jacobs Levy Equity Management
2
Jacobs Levy Equity Management
New Jersey
$190K
3
Wells Fargo
3
Wells Fargo
California
$40K
4
Jane Street
4
Jane Street
New York
$81K
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$35K

Top Sellers

1
SFS
1
Sowell Financial Services
Arkansas
$302K
2
Millennium Management
2
Millennium Management
New York
$25K
3
SIM
3
Spark Investment Management
New York
$44K
4
Goldman Sachs
4
Goldman Sachs
New York
$109K
5
TRCT
5
Tower Research Capital (TRC)
New York
$2K
Name Holding Trade Value Shares
Change 		Shares
Change %
MFW
51
Mosaic Family Wealth
Missouri
$1K – – –
CPIG
52
Chicago Partners Investment Group
Illinois
$1K +$1K +174 New
1 2
3